ALPA · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 44/100 — Quality 34 · Valuation 85 · Momentum 0
| Share price | ₹68.55 |
| Market cap | ₹144 Cr |
| P/E ratio | 9.6 |
| P/B ratio | 2.1 |
| ROE | 71.3% |
| ROCE | 8.9% |
| Book value | ₹32.34 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹106 Cr | ₹15 Cr | 3.0% |
| 2025 | ₹110 Cr | ₹20 Cr | 4.0% |
| 2024 | ₹109 Cr | ₹17 Cr | 8.0% |
| 2023 | ₹93 Cr | ₹13 Cr | 9.0% |
| 2022 | ₹112 Cr | ₹14 Cr | 10.0% |
Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It provides formulations that address various therapeutic segments. The company was incorporated in 1988 and is based in Indore, India.